Detalhe da pesquisa
1.
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.
Int J Mol Sci
; 21(20)2020 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33096780
2.
[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.
Oncologist
; 20(5): 539-45, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25876992
3.
Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection.
Blood
; 121(8): 1357-66, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23243276
4.
Pneumococcal pneumonia infection is associated with end-stage renal disease in adult hospitalized patients.
Kidney Int
; 86(5): 1023-30, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24694991
5.
Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic pathways.
Toxicol Appl Pharmacol
; 279(3): 351-363, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25018059
6.
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression.
Am J Cancer Res
; 14(4): 1850-1865, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726266
7.
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy.
Nat Cancer
; 5(3): 400-419, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267627
8.
Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment.
Mol Oncol
; 17(8): 1648-1665, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37013960
9.
A disintegrin and metalloproteinase domain 9 facilitates SARS-CoV-2 entry into cells with low ACE2 expression.
Microbiol Spectr
; : e0385422, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713503
10.
Articulatin B chain induced dendritic cells maturation and driven type I T helper cells and cytotoxic T cells activation.
Life Sci
; 302: 120635, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569571
11.
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma.
Comput Struct Biotechnol J
; 20: 4626-4635, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36090818
12.
ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma.
Int J Biol Sci
; 17(14): 3898-3910, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671207
13.
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma.
Mol Ther Nucleic Acids
; 25: 1-10, 2021 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34141460
14.
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
Theranostics
; 11(8): 3661-3675, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33664854
15.
Resveratrol-mediated ADAM9 degradation decreases cancer progression and provides synergistic effects in combination with chemotherapy.
Am J Cancer Res
; 10(11): 3828-3837, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294270
16.
Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
Int J Oncol
; 56(1): 165-177, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31789397
17.
The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.
Am J Cancer Res
; 10(8): 2621-2634, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32905506
18.
Erratum: The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.
Am J Cancer Res
; 10(10): 3507, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33163286
19.
A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor Immunity.
Vaccines (Basel)
; 8(4)2020 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33096846
20.
EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis.
Redox Biol
; 34: 101571, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446175